(NASDAQ: ACET) Adicet Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 43.26%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.52%.
Adicet Bio's earnings in 2025 is -$115,014,000.On average, 9 Wall Street analysts forecast ACET's earnings for 2025 to be -$172,213,296, with the lowest ACET earnings forecast at -$187,738,087, and the highest ACET earnings forecast at -$165,745,911. On average, 9 Wall Street analysts forecast ACET's earnings for 2026 to be -$126,619,761, with the lowest ACET earnings forecast at -$159,201,898, and the highest ACET earnings forecast at -$106,206,118.
In 2027, ACET is forecast to generate -$134,435,796 in earnings, with the lowest earnings forecast at -$169,715,230 and the highest earnings forecast at -$104,596,934.